Orchard Therapeutics' Grant

Orchard Therapeutics raised a round of funding on November 26, 2016. Investors include California Institute of Regenerative Medicine.

Orchard Therapeutics (ORTX) is a biotechnology company focused on the development and commercialization of transformative ex-vivo gene therapies for patients with orphan diseases. Orchard's developmen…

Articles about Orchard Therapeutics' Grant: